Net product and solutions revenue from our health and wellness Details Solutions segment was $134.2 million in the third quarter of 2013, in comparison to $135.1 million in the third quarter of 2012 and $134.8 million in the next quarter of 2013. Included in interest and other income , net can be a provision of $5.0 million to reflect an estimate of the settlement or litigation costs which we may incur associated with a continuing dispute with a customer in our U.S. Toxicology business. The Business's GAAP outcomes for the third one fourth of 2013 exclude $0.5 million of revenue associated with acquired software license contracts that are not recognized due to business combination accounting rules and include amortization of $82.4 million, $7.8 million of restructuring charges, $5.7 million of stock-based compensation expense, $0.5 million of acquisition-related costs recorded relative to ASC 805, Business Mixtures, $2.7 million of expense recorded for fair value changes to acquisition-related contingent consideration, $0.4 million of interest expense recorded regarding the fees payed for certain debt modifications, $0.8 million in compensation charges and $0.1 million of related interest accretion connected with acquisition-related contingent consideration obligations, a $0.7 million charge associated with the write-up to fair market value of inventory acquired regarding the the acquisition of Epocal Inc., $5.5 million of costs associated with the proxy contest, a $5.9 million loss associated with the disposition of our Spinreact, S.A.In HCV care, the device targets to improve patient cure prices as an adjunct to accelerate and improve the performance of current and future iterations of standard of care drug therapy.
14 says now reporting meningitis cases WASHINGTON Federal wellness officials are reporting the true number of instances of fungal meningitis provides risen to 205. The Centers for Disease Control and Prevention says the true number of deaths stands at 15. Fourteen states are actually reporting cases. The latest is New Hampshire. Others include Florida, Idaho, Illinois, Indiana, Maryland, Michigan, Minnesota, NJ, NEW YORK, Ohio, Tennessee, Virginia and Texas. The outbreak offers been linked to steroid shots useful for back pain created by a specialty pharmacy in Massachusetts.